Sugino Y, Usui T, Okubo K, Nagahama K, Takahashi T, Okuno H, Hatayama H, Ogawa O, Shimatsu A, Nishiyama H
Department of Urology, Kyoto University, Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
J Assist Reprod Genet. 2006 Sep-Oct;23(9-10):377-80. doi: 10.1007/s10815-006-9062-0. Epub 2006 Oct 11.
We describe here two infertile male patients who were referred to our hospital with azoospermia at the ages of 33 and 30 years, respectively. Hormonal examinations led to a diagnosis of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency in both patients. Genotyping revealed that the patients had a homozygous I172N and a heterozygous compound I172N/IVS2-13A/C>G mutation, respectively. Glucocorticoid replacement therapy succeeded in improving the seminal status of one patient, but not the other. For the latter patient and his wife, a pregnancy was achieved by testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) following genetic counseling. It is important to investigate genotyping and to classify patients on the basis of genotypic information in order to arrive at better treatment strategies for male infertility; especially in counseling of TESE-ICSI.
我们在此描述两名不育男性患者,他们分别在33岁和30岁时因无精子症被转诊至我院。激素检查结果显示,两名患者均因21-羟化酶缺乏而被诊断为先天性肾上腺皮质增生症(CAH)。基因分型显示,两名患者分别有纯合子I172N和杂合子复合突变I172N/IVS2-13A/C>G。糖皮质激素替代疗法成功改善了其中一名患者的精液状况,但对另一名患者无效。对于后一名患者及其妻子,在接受遗传咨询后,通过睾丸精子提取(TESE)和卵胞浆内单精子注射(ICSI)成功受孕。为了制定更好的男性不育治疗策略,尤其是在TESE-ICSI咨询中,重要的是要进行基因分型并根据基因信息对患者进行分类。